Evaluating unconventional therapies.
Hajto
T
T
Saller
R
R
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D000529:Complementary Therapies; D006801:Humans; D037102:Lectins / Q000627:therapeutic use*; D014784:Mistletoe / Q000737:chemistry / Q000627:therapeutic use*; D008517:Phytotherapy; D010936:Plant Extracts / Q000009:adverse effects*; D037121:Plant Lectins; D028321:Plant Preparations; D010940:Plant Proteins; D010946:Plants, Medicinal; D054790:Ribosome Inactivating Proteins, Type 2; D014118:Toxins, Biological / Q000009:adverse effects*
D000276:Adjuvants, Immunologic; D037102:Lectins; D010936:Plant Extracts; D037121:Plant Lectins; D028321:Plant Preparations; D010940:Plant Proteins; D054790:Ribosome Inactivating Proteins, Type 2; D014118:Toxins, Biological; C009674:ribosome inactivating protein, Viscum